Cargando…

Role of Blood Stasis Syndrome of Kampo Medicine in the Early Pathogenic Stage of Atherosclerosis: A Retrospective Cross-Sectional Study

In Kampo medicine, blood stasis (BS) syndrome is strongly associated with microangiopathy and can lead to atherosclerosis. Vascular endothelial dysfunction (VED), evaluated through flow-mediated dilation (FMD), plays an important role in the early stages of atherosclerosis. However, the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Akira, Namiki, Takao, Nakaguchi, Toshiya, Murai, Kazunari, Watanabe, Yuki, Nakamura, Michimi, Kawasaki, Yohei, Shiko, Yuki, Tamura, Yutaka, Suganami, Akiko, Murakami, Aya, Yagi, Akio, Okamoto, Hideki, Hirasaki, Yoshiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175131/
https://www.ncbi.nlm.nih.gov/pubmed/34135979
http://dx.doi.org/10.1155/2021/5557392
_version_ 1783702990961508352
author Morita, Akira
Namiki, Takao
Nakaguchi, Toshiya
Murai, Kazunari
Watanabe, Yuki
Nakamura, Michimi
Kawasaki, Yohei
Shiko, Yuki
Tamura, Yutaka
Suganami, Akiko
Murakami, Aya
Yagi, Akio
Okamoto, Hideki
Hirasaki, Yoshiro
author_facet Morita, Akira
Namiki, Takao
Nakaguchi, Toshiya
Murai, Kazunari
Watanabe, Yuki
Nakamura, Michimi
Kawasaki, Yohei
Shiko, Yuki
Tamura, Yutaka
Suganami, Akiko
Murakami, Aya
Yagi, Akio
Okamoto, Hideki
Hirasaki, Yoshiro
author_sort Morita, Akira
collection PubMed
description In Kampo medicine, blood stasis (BS) syndrome is strongly associated with microangiopathy and can lead to atherosclerosis. Vascular endothelial dysfunction (VED), evaluated through flow-mediated dilation (FMD), plays an important role in the early stages of atherosclerosis. However, the association of BS syndrome with VED, as determined using FMD, has not been reported. This study investigated the association between BS syndrome and VED using FMD. Forty-one patients with normal glucose tolerance or impaired glucose tolerance (IGT) and without macrovascular complications were evaluated using FMD from May 2017 to August 2017. Based on the BS score, the patients were divided into the non-BS (n = 19) and BS syndrome (n = 22) groups. Physical and background characteristics, physiological function test results, and laboratory data were compared. Univariate analysis revealed that FMD and a history of dyslipidemia/IGT were significantly different between the two groups (p < 0.05). Multiple logistic regression analysis showed that BS syndrome was significantly associated with FMD (odds ratio: 6.26; p=0.03) after adjusting for the history of dyslipidemia/IGT. The receiver operating characteristic curve showed that the area under the curve for BS syndrome (0.74; p < 0.001) and history of IGT (p < 0.007) provided good diagnostic accuracy for FMD. The area under the curve for “BS syndrome + IGT” showed very good accuracy (0.80; p < 0.0001) and was higher than that for BS syndrome or IGT alone. In conclusion, the results of this study suggest that the BS score in Kampo medicine could be a useful tool for detecting the early pathogenic stages of atherosclerosis.
format Online
Article
Text
id pubmed-8175131
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-81751312021-06-15 Role of Blood Stasis Syndrome of Kampo Medicine in the Early Pathogenic Stage of Atherosclerosis: A Retrospective Cross-Sectional Study Morita, Akira Namiki, Takao Nakaguchi, Toshiya Murai, Kazunari Watanabe, Yuki Nakamura, Michimi Kawasaki, Yohei Shiko, Yuki Tamura, Yutaka Suganami, Akiko Murakami, Aya Yagi, Akio Okamoto, Hideki Hirasaki, Yoshiro Evid Based Complement Alternat Med Research Article In Kampo medicine, blood stasis (BS) syndrome is strongly associated with microangiopathy and can lead to atherosclerosis. Vascular endothelial dysfunction (VED), evaluated through flow-mediated dilation (FMD), plays an important role in the early stages of atherosclerosis. However, the association of BS syndrome with VED, as determined using FMD, has not been reported. This study investigated the association between BS syndrome and VED using FMD. Forty-one patients with normal glucose tolerance or impaired glucose tolerance (IGT) and without macrovascular complications were evaluated using FMD from May 2017 to August 2017. Based on the BS score, the patients were divided into the non-BS (n = 19) and BS syndrome (n = 22) groups. Physical and background characteristics, physiological function test results, and laboratory data were compared. Univariate analysis revealed that FMD and a history of dyslipidemia/IGT were significantly different between the two groups (p < 0.05). Multiple logistic regression analysis showed that BS syndrome was significantly associated with FMD (odds ratio: 6.26; p=0.03) after adjusting for the history of dyslipidemia/IGT. The receiver operating characteristic curve showed that the area under the curve for BS syndrome (0.74; p < 0.001) and history of IGT (p < 0.007) provided good diagnostic accuracy for FMD. The area under the curve for “BS syndrome + IGT” showed very good accuracy (0.80; p < 0.0001) and was higher than that for BS syndrome or IGT alone. In conclusion, the results of this study suggest that the BS score in Kampo medicine could be a useful tool for detecting the early pathogenic stages of atherosclerosis. Hindawi 2021-05-26 /pmc/articles/PMC8175131/ /pubmed/34135979 http://dx.doi.org/10.1155/2021/5557392 Text en Copyright © 2021 Akira Morita et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Morita, Akira
Namiki, Takao
Nakaguchi, Toshiya
Murai, Kazunari
Watanabe, Yuki
Nakamura, Michimi
Kawasaki, Yohei
Shiko, Yuki
Tamura, Yutaka
Suganami, Akiko
Murakami, Aya
Yagi, Akio
Okamoto, Hideki
Hirasaki, Yoshiro
Role of Blood Stasis Syndrome of Kampo Medicine in the Early Pathogenic Stage of Atherosclerosis: A Retrospective Cross-Sectional Study
title Role of Blood Stasis Syndrome of Kampo Medicine in the Early Pathogenic Stage of Atherosclerosis: A Retrospective Cross-Sectional Study
title_full Role of Blood Stasis Syndrome of Kampo Medicine in the Early Pathogenic Stage of Atherosclerosis: A Retrospective Cross-Sectional Study
title_fullStr Role of Blood Stasis Syndrome of Kampo Medicine in the Early Pathogenic Stage of Atherosclerosis: A Retrospective Cross-Sectional Study
title_full_unstemmed Role of Blood Stasis Syndrome of Kampo Medicine in the Early Pathogenic Stage of Atherosclerosis: A Retrospective Cross-Sectional Study
title_short Role of Blood Stasis Syndrome of Kampo Medicine in the Early Pathogenic Stage of Atherosclerosis: A Retrospective Cross-Sectional Study
title_sort role of blood stasis syndrome of kampo medicine in the early pathogenic stage of atherosclerosis: a retrospective cross-sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175131/
https://www.ncbi.nlm.nih.gov/pubmed/34135979
http://dx.doi.org/10.1155/2021/5557392
work_keys_str_mv AT moritaakira roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT namikitakao roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT nakaguchitoshiya roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT muraikazunari roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT watanabeyuki roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT nakamuramichimi roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT kawasakiyohei roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT shikoyuki roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT tamurayutaka roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT suganamiakiko roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT murakamiaya roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT yagiakio roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT okamotohideki roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy
AT hirasakiyoshiro roleofbloodstasissyndromeofkampomedicineintheearlypathogenicstageofatherosclerosisaretrospectivecrosssectionalstudy